EUVIMEDEUVIMED entdecken
Crossref

Adoptive immunotherapy of cancer using effector lymphocytes redirected with antibody specificity

Dinorah Friedmann-Morvinski, Zelig Eshhar

Update on Cancer Therapeutics · 2006

DOI: 10.1016/j.uct.2006.04.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Update on Cancer Therapeutics, 2006. Verfasst von Dinorah Friedmann-Morvinski und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Friedmann-Morvinski, D., & Eshhar, Z. (2006). Adoptive immunotherapy of cancer using effector lymphocytes redirected with antibody specificity. Update on Cancer Therapeutics. https://doi.org/10.1016/j.uct.2006.04.005

Vancouver

Friedmann-Morvinski D, Eshhar Z. Adoptive immunotherapy of cancer using effector lymphocytes redirected with antibody specificity. Update on Cancer Therapeutics. 2006. doi:10.1016/j.uct.2006.04.005

BibTeX
@article{FriedmannMorvinski2006,
  author = {Friedmann-Morvinski, Dinorah and Eshhar, Zelig},
  title = {Adoptive immunotherapy of cancer using effector lymphocytes redirected with antibody specificity},
  journal = {Update on Cancer Therapeutics},
  year = {2006},
  doi = {10.1016/j.uct.2006.04.005}
}
Kostenlos starten →